Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Eastern Washington Clinical Research Center
mi
from
Spokane, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Eastern Washington Clinical Research Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Spokane Digestive Disease Center
mi
from
Spokane, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Spokane Digestive Disease Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Digestive Disease Research Center
mi
from
Tacoma, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Digestive Disease Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Center for Advanced Research
mi
from
Milwaukee, WI
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Center for Advanced Research
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Histology Post-Endoscopic Eradication Therapy (EET)
Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus
Status: Enrolling
Updated:  12/11/2017
Northwestern University
mi
from
Chicago, IL
Histology Post-Endoscopic Eradication Therapy (EET)
Optimizing Patient Outcomes Through Early Detection of Uncontrolled Acid Reflux After Endoscopic Therapy in Barrett's Esophagus
Status: Enrolling
Updated: 12/11/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study.
Status: Enrolling
Updated:  12/12/2017
University of Iowa Department of Otolaryngology
mi
from
Iowa City, IA
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study.
Status: Enrolling
Updated: 12/12/2017
University of Iowa Department of Otolaryngology
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cimzia Versus Mesalamine for Crohn's Recurrence
Use of Certolizumab Following Ileocolectomy Lowers Endoscopic and Histological Recurrence Rates for Crohn's Disease at One Year Compared to Mesalamine
Status: Enrolling
Updated:  12/13/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Cimzia Versus Mesalamine for Crohn's Recurrence
Use of Certolizumab Following Ileocolectomy Lowers Endoscopic and Histological Recurrence Rates for Crohn's Disease at One Year Compared to Mesalamine
Status: Enrolling
Updated: 12/13/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess Safety, Tolerability And Pharmacokinetics Of Single, Escalating, Oral Doses Of Pf-06835919 In Healthy Adult Subjects
Status: Enrolling
Updated:  12/13/2017
Pfizer New Haven Clinical Research Unit
mi
from
New Haven, CT
Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess Safety, Tolerability And Pharmacokinetics Of Single, Escalating, Oral Doses Of Pf-06835919 In Healthy Adult Subjects
Status: Enrolling
Updated: 12/13/2017
Pfizer New Haven Clinical Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.
Status: Enrolling
Updated:  12/14/2017
University of Louisville Hospital
mi
from
Louisville, KY
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.
Status: Enrolling
Updated: 12/14/2017
University of Louisville Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
The University of Chicago Hospitals
mi
from
Chicago, IL
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
The University of Chicago Hospitals
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Maryland Digestive Diseases Research
mi
from
Laurel, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Maryland Digestive Diseases Research
mi
from
Laurel, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Capitol Gastroenterology Consultants
mi
from
Silver Spring, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Capitol Gastroenterology Consultants
mi
from
Silver Spring, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Atlantic Gastroenterology Associates
mi
from
Egg Harbor Township, NJ
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Atlantic Gastroenterology Associates
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)
A Pilot Evaluation of the Effect of the Erchonia Verjú™ and EVRL Lasers on Reducing Aminoalanine Transaminase (ALT) in Individuals With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/14/2017
Meridian Integrative Medicine
mi
from
Scottsdale, AZ
A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)
A Pilot Evaluation of the Effect of the Erchonia Verjú™ and EVRL Lasers on Reducing Aminoalanine Transaminase (ALT) in Individuals With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/14/2017
Meridian Integrative Medicine
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Advanced Clinical Therapeutics
mi
from
Tucson, AZ
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Advanced Clinical Therapeutics
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Rx Trials
mi
from
Washington,
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Rx Trials
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Pinnacle Trials
mi
from
Atlanta, GA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Pinnacle Trials
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Saint Joseph's Health System, Inc.
mi
from
Atlanta, GA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Saint Joseph's Health System, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Northwestern University School of Medicine
mi
from
Chicago, IL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Northwestern University School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
University of Chicago
mi
from
Chicago, IL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
University of Louisville
mi
from
Louisville, KY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Asher Kornbluth, MD PC
mi
from
New York, NY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Asher Kornbluth, MD PC
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Atilla Ertan
mi
from
Houston, TX
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Atilla Ertan
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Mcguire Dvamc
mi
from
Richmond, VA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Dean Foundation Research Center
mi
from
Madison, WI
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Dean Foundation Research Center
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Vancouver General Hospital
mi
from
Vancouver,
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Vancouver General Hospital
mi
from
Vancouver,
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated:  12/15/2017
Venture Research
mi
from
North Miami Beach, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008
Status: Enrolling
Updated: 12/15/2017
Venture Research
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
Dothan, AL
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
Dothan, AL
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
Tucson, AZ
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
Coronado, CA
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
Coronado, CA
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
Los Angeles, CA
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
Rialto, CA
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
Rialto, CA
Click here to add this to my saved trials
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated:  12/15/2017
Madrigal Research Site
mi
from
San Diego, CA
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis
Status: Enrolling
Updated: 12/15/2017
Madrigal Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials